StockNews.com assumed coverage on shares of NantHealth (NASDAQ:NH – Get Rating) in a report issued on Tuesday morning. The brokerage issued a hold rating on the stock.
NantHealth Stock Performance
NASDAQ:NH opened at $2.26 on Tuesday. NantHealth has a one year low of $1.57 and a one year high of $11.98. The stock has a market cap of $17.42 million, a PE ratio of -0.30 and a beta of 1.86. The stock has a 50 day moving average price of $2.98 and a 200 day moving average price of $1.72.
Get
NantHealth alerts:
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of NH. Atria Wealth Solutions Inc. boosted its position in shares of NantHealth by 117.7% during the second quarter. Atria Wealth Solutions Inc. now owns 491,942 shares of the company's stock worth $205,000 after buying an additional 265,949 shares during the period. Millennium Management LLC purchased a new position in shares of NantHealth during the second quarter worth $110,000. Finally, Goldman Sachs Group Inc. purchased a new position in shares of NantHealth during the second quarter worth $36,000. 4.50% of the stock is currently owned by hedge funds and other institutional investors.
NantHealth Company Profile
(Get Rating)
NantHealth, Inc is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. The firm empowers treatment decisions, improves patient outcomes, validates treatment options, enables high-quality care, lowers costs, ensures appropriate reimbursement, and streamlines implementation and deployment.
Featured Stories
- Get a free copy of the StockNews.com research report on NantHealth (NH)
- Dividend King Genuine Parts Company Upgraded On Profit Guidance
- The Bottom Is In For Accenture
- 11 Best Consumer Discretionary Stocks of 2023
- 5 Best Dividend Capture Stocks
- 10 Best Consumer Discretionary ETFs
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.
StockNews.com承擔了對以下股票的報道NantHealth(納斯達克:NH-GET評級)在週二上午發佈的一份報告中。該券商對該股發佈了持有評級。
NantHealth股票表現
納斯達克:NH週二開盤報2.26美元。NantHealth的一年低點為1.57美元,一年高位為11.98美元。該股市值為1,742萬美元,本益比為-0.30,貝塔係數為1.86。該股的50日移動均價為2.98美元,200日移動均價為1.72美元。
到達
NantHealth警報:
機構資金流入和流出
幾家對沖基金和其他機構投資者最近調整了對NH的持股。Atria Wealth Solutions Inc.在第二季度將其在NantHealth的股票頭寸增加了117.7%。Atria Wealth Solutions Inc.在此期間又購買了265,949股Atria Wealth Solutions Inc.,目前持有491,942股該公司股票,價值20.5萬美元。Millennium Management LLC在第二季度購買了價值11萬美元的NantHealth新股頭寸。最後,高盛股份有限公司在第二季度購買了價值36,000美元的南洋健康新股頭寸。4.50%的股票目前由對沖基金和其他機構投資者持有。
NantHealth公司簡介
(獲取評級)
NantHealth,Inc.是一家以證據為基礎的個性化保健公司,致力於為癌症等危重疾病提供治療。該公司支持治療決策,改善患者結局,驗證治療選項,實現高質量護理,降低成本,確保適當的報銷,並簡化實施和部署。
專題報道
- 免費獲取StockNews.com關於NantHealth(NH)的研究報告
- 紅利王正品配件公司利潤指引升級
- 埃森哲的底部已經到了
- 2023年11只最佳非必需消費品股票
- 5只最佳股利捕捉股
- 十大最佳消費者可自由支配ETF
接受《NantHealth Daily》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對NantHealth和相關公司的最新新聞和分析師評級的每日簡要摘要。